|
|
|
|
 |
|
| Nutra Pharma is developing an innovative
pipeline of biopharmaceutical products |
|
|
|
|
|
|
|
|
|
|
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
|
|
|
Below you will find the most recent Nutra Pharma
press releases. To view press releases from previous
years, please visit the Archives.
June 08, 2009
Nutra Pharma Announces Study Showing RPI-78 More Effective than Morphine in the Treatment of Moderate to Severe Pain
March 26, 2009
Nutra Pharma Subsidiary, ReceptoPharm, Introduces Cost Effective Contract Research Services for Early Stage Life Science Firms
March 09, 2009
Nutra Pharma Subsidiary, ReceptoPharm, Announces Achievement of ISO Class 5 Cleanroom Certification
February 17, 2009
Nutra Pharma Announces Publication of Positive Results of ReceptoPharm Arthritis Study
February 09, 2009
Nutra Pharma Subsidiary, ReceptoPharm, Files Patent Application for Novel Treatment of Arthritis Using RPI-78
December 08, 2008
Nutra Pharma Receives Clinical Drug Supply Contract
November 17, 2008
Nutra Pharma Announces Provision of RPI-78M under Compassionate Release to Adrenomyeloneuropathy (AMN) Patients
August 14, 2008
Nutra Pharma Announces Initial Positive Safety Data from Clinical Study in Adrenomyeloneuropathy (AMN)
August 06, 2008
Nutra Pharma Announces Collaborative Agreement with Centers for Disease Control and Prevention (CDC)
August 01, 2008
August 2008 Shareholder Letter from Chairman and CEO Rik J. Deitsch
|
|
|
| |
|
|
|
| |
|
| Click
Here to learn about Nutra Pharma’s focus on
financial sustainability. |
|
|
|
|
| |
|
|
|
|
